These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33052280)

  • 1. Hydatidiform Mole in a Patient With a Concern for Neoplasia: A Case Report.
    Prabhu IK; Rosenbaum A
    Cureus; 2020 Sep; 12(9):e10319. PubMed ID: 33052280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gestational Trophoblastic Disease: Complete versus Partial Hydatidiform Moles.
    Gonzalez J; Popp M; Ocejo S; Abreu A; Bahmad HF; Poppiti R
    Diseases; 2024 Jul; 12(7):. PubMed ID: 39057130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent hydatidiform mole: A case report of six consecutive molar pregnancies complicated by choriocarcinoma, and review of the literature.
    Al-Ghamdi AA
    J Family Community Med; 2011 Sep; 18(3):159-61. PubMed ID: 22175045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent partial hydatidiform mole: a report of a patient with three consecutive molar pregnancies.
    Koc S; Ozdegirmenci O; Tulunay G; Ozgul N; Kose MF; Bulbul D
    Int J Gynecol Cancer; 2006; 16(2):940-3. PubMed ID: 16681793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy.
    Sebire NJ; Fisher RA; Foskett M; Rees H; Seckl MJ; Newlands ES
    BJOG; 2003 Jan; 110(1):22-6. PubMed ID: 12504931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
    Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
    Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total laparoscopic hysterectomy in combination with dilation and evacuation of an 18-week-sized uterus with gestational trophoblastic neoplasia: a novel treatment approach.
    Patel M; Stuparich M; Nahas S
    Am J Obstet Gynecol; 2021 Mar; 224(3):314-315. PubMed ID: 33197418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Centralized surveillance of hydatidiform mole: 7-year experience from a regional hospital in China.
    Jiao L; Wang Y; Jiang J; Wang X; Zhang W; Zhu C; Xiang Y
    Int J Gynecol Cancer; 2022 Feb; 32(2):147-152. PubMed ID: 34799419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unusual Presentation of Invasive Mole: A Case Report.
    Aminimoghaddam S; Maghsoudnia A
    J Reprod Infertil; 2017; 18(1):205-209. PubMed ID: 28377901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Routine pre-evacuation ultrasound diagnosis of hydatidiform mole: experience of more than 1000 cases from a regional referral center.
    Fowler DJ; Lindsay I; Seckl MJ; Sebire NJ
    Ultrasound Obstet Gynecol; 2006 Jan; 27(1):56-60. PubMed ID: 16273594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of recurrent molar pregnancies following complete and partial hydatidiform moles.
    Eagles N; Sebire NJ; Short D; Savage PM; Seckl MJ; Fisher RA
    Hum Reprod; 2015 Sep; 30(9):2055-63. PubMed ID: 26202916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraplacental choriocarcinoma arising in a second trimester placenta with partial hydatidiform mole.
    Medeiros F; Callahan MJ; Elvin JA; Dorfman DM; Berkowitz RS; Quade BJ
    Int J Gynecol Pathol; 2008 Apr; 27(2):247-51. PubMed ID: 18317216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive mole with lung metastasis after an abdominal complete hydatidiform mole treatment.
    Suzuki S; Takahashi K; Obayashi S; Kitazawa M; Kuroda H; Fukasawa I
    J Obstet Gynaecol Res; 2021 Jan; 47(1):420-424. PubMed ID: 33078868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct microRNA profiles for complete hydatidiform moles at risk of malignant progression.
    Lin LH; Maestá I; St Laurent JD; Hasselblatt KT; Horowitz NS; Goldstein DP; Quade BJ; Sun SY; Braga A; Fisher RA; Berkowitz RS; Elias KM
    Am J Obstet Gynecol; 2021 Apr; 224(4):372.e1-372.e30. PubMed ID: 33031755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial hydatidiform mole with false-negative urine human chorionic gonadatropin test in the emergency department.
    Mundangepfupfu T; Waseem M
    J Emerg Med; 2014 Mar; 46(3):348-50. PubMed ID: 24188605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choriocarcinoma following a partial hydatidiform mole: a case report.
    Gardner HA; Lage JM
    Hum Pathol; 1992 Apr; 23(4):468-71. PubMed ID: 1563750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of maspin in gestational trophoblastic disease.
    Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
    Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemistry in the diagnosis of the gestational trophoblastic disease.
    Lösch A; Kainz C
    Acta Obstet Gynecol Scand; 1996 Sep; 75(8):753-6. PubMed ID: 8906012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of hydatidiform mole and choriocarcinoma.
    Bracken MB; Brinton LA; Hayashi K
    Epidemiol Rev; 1984; 6():52-75. PubMed ID: 6386504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Her-2/neu expression in hydatidiform moles for prediction of subsequent gestational trophoblastic neoplasia.
    Menczer J; Schreiber L; Berger E; Golan A; Levy T
    Gynecol Oncol; 2007 Mar; 104(3):675-9. PubMed ID: 17126893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.